CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The new online Learning Center with new content can still be found under the “Training” folder on ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...